Dr Leslie Lobel of Ben Gurion University has identified antibody clones from patients who have recovered from Hepatitis C Virus (HCV) infections. BGU has now entered into an agreement with San Diego-based Sorrento Therapeutics to develop the clones into anti-HCV therapeutics
http://in.bgu.ac.il/en/Pages/news/sorrento_agreement.aspx